„Jorge and I had a chance to work together on the first software as a medical device ever released by Roche, with applications in the neuroimmulogy and neurodegenerative space. It was a pleasure to work with him on this journey to drive disruptive innovation in healthcare. Jorge was an incredibly thoughful, calm and inspiring leader. He managed to provide insightful perspectives that would nudge the teams in the right direction. He took the time to deeply listen, ask probing questions to get to the bottom of issues, and took all of that information into consideration to make effective recommendations allowing the team to succeed. He is an inspired product leader that any product team would be lucky to count amongst its ranks, especially if you are working on highly innovative and disruptive products that require a high tolerance for ambiguity, resilience and steady leadership.“
Jorge Cancela
Nyon, Waadt, Schweiz
5487 Follower:innen
500+ Kontakte
Info
Aktivitäten
-
An important step forward! Not the solution to all challenges, but a much needed boost. I’m optimistic, we will see how it goes. #dtx…
An important step forward! Not the solution to all challenges, but a much needed boost. I’m optimistic, we will see how it goes. #dtx…
Beliebt bei Jorge Cancela
-
“The current study begins to answer important questions that move beyond whether wearables can safely and reliably detect arrhythmias, to…
“The current study begins to answer important questions that move beyond whether wearables can safely and reliably detect arrhythmias, to…
Geteilt von Jorge Cancela
-
Check out a recent Nature Medicine paper from our team and some amazing collaborators which demonstrates how sleep stages, duration, and regularity…
Check out a recent Nature Medicine paper from our team and some amazing collaborators which demonstrates how sleep stages, duration, and regularity…
Beliebt bei Jorge Cancela
Berufserfahrung und Ausbildung
Veröffentlichungen
Auszeichnungen/Preise
-
Excellence in Innovation Award
PMEA
The Merck eHealth programme for growth hormone was recognized in the Pharmaceutical Marketing Excellence Awards (PMEA) 2017 Awards with:
• Winner of Excellence in Innovation Award.
• High commendation in the Excellence in Engagement through Multiple Channels Award.
• Shortlisted in the Excellence Creating Value Beyond the Product Award.
The PMEA judges commented: “Merck’s project was truly innovative. The eHealth technology is a fantastic example of triage between patient…The Merck eHealth programme for growth hormone was recognized in the Pharmaceutical Marketing Excellence Awards (PMEA) 2017 Awards with:
• Winner of Excellence in Innovation Award.
• High commendation in the Excellence in Engagement through Multiple Channels Award.
• Shortlisted in the Excellence Creating Value Beyond the Product Award.
The PMEA judges commented: “Merck’s project was truly innovative. The eHealth technology is a fantastic example of triage between patient, carer and healthcare professional, particularly engaging the children/teenagers in an impressive way. They have remarkable adherence rates generated from both the device and study.”
http://www.pmlive.com/awards/pmea/awards_archive/pmea_awards_2017_results/company_awards/excellence_in_innovation
-
Best Business Idea XIII Competición actúaupm
Universidad Politécnica de Madrid
http://actuaupm.blogspot.com.es/2016/04/la-xiii-competicion-actuaupm-alcanza.html
-
Winner EIT Health Design Thinking Competition
Openlab, Karolinska Institutet, Roche, EIT Health
-
2015 IDEA² Madrid Awardee
Madrid-MIT M+Visión Consortium
The Madrid-MIT M+Visión Consortium, a partnership of the regional government of Madrid and the Massachusetts Institute of Technology (MIT). The IDEA² program helps emerging innovators living and working in Madrid to refine their biomedical technology ideas and turn them into projects with higher potential for healthcare impact.
The idea presented was mPark: An mHealth tool for the rehabilitation of Parkinson’s Disease. mPark is aimed at building a mHealth (mobile health) solution for…The Madrid-MIT M+Visión Consortium, a partnership of the regional government of Madrid and the Massachusetts Institute of Technology (MIT). The IDEA² program helps emerging innovators living and working in Madrid to refine their biomedical technology ideas and turn them into projects with higher potential for healthcare impact.
The idea presented was mPark: An mHealth tool for the rehabilitation of Parkinson’s Disease. mPark is aimed at building a mHealth (mobile health) solution for rehabilitation using platforms already available in the market such as smartphones and smartwatches. Specifically, mPark is aimed at addressing Parkinson’s disease (PD) and to explore the feasibility of extending this approach to other conditions.
http://mvisionconsortium.org/2015-idea²-madrid-awardees/ -
Award on the I Idea contest UPM-Samsung
Samsung Electronic Iberia S.A.U, Universidad Politecnica de Madrid and Cátedra Ingenio-UPM.
aMate - a wearable affective companion - was awarded in the I Idea contest UPM-Samsung about wearable technologies
http://concursosamsung.etsisi.upm.es/ -
Merit prize at the Young Investigator Award 2015
International Federation for Medical and Biological Engineering
Presentation: A mobile monitoring tool for the automatic activity recognition and its application for Parkinson's disease rehabilitation
http://ifmbe.org/ifmbe-yia/ -
Shorlisted on the I Wayra edition
http://wayra.co/es
mobileHome shorlisted to enter Wayra academy on its first edition
http://wayra.co/es
Erhaltene Empfehlungen
6 Personen haben Jorge Cancela empfohlen
Jetzt anmelden und ansehenWeitere Aktivitäten von Jorge Cancela
-
With the news that Meta is cutting budgets and headcount at Reality labs, reposting this from last week - 'the VR Winter Continues'. The problem…
With the news that Meta is cutting budgets and headcount at Reality labs, reposting this from last week - 'the VR Winter Continues'. The problem…
Beliebt bei Jorge Cancela
-
In first half of 2024, we've seen $106B in healthcare M&A transaction value. On the surface, that looks like a healthy market for the…
In first half of 2024, we've seen $106B in healthcare M&A transaction value. On the surface, that looks like a healthy market for the…
Beliebt bei Jorge Cancela
-
Jim Joyce and I seem to be consistently inconsistent with #TheShot of #DigitalHealth Therapy but we welcome you all to Episode #142 which is as…
Jim Joyce and I seem to be consistently inconsistent with #TheShot of #DigitalHealth Therapy but we welcome you all to Episode #142 which is as…
Beliebt bei Jorge Cancela
-
Economists trying to do top-down estimates of the share of work that will be affected by generative AI make me wonder about trying the same exercise…
Economists trying to do top-down estimates of the share of work that will be affected by generative AI make me wonder about trying the same exercise…
Beliebt bei Jorge Cancela
-
Our solution, Hospital@Home, has been chosen as a finalist in the 'Best Digital Health Project 2024' category of the New Medical Economics Awards…
Our solution, Hospital@Home, has been chosen as a finalist in the 'Best Digital Health Project 2024' category of the New Medical Economics Awards…
Beliebt bei Jorge Cancela
-
“Enrollment duration — measured as the time from trial start to enrollment close — for all industry-sponsored interventional clinical trials…
“Enrollment duration — measured as the time from trial start to enrollment close — for all industry-sponsored interventional clinical trials…
Geteilt von Jorge Cancela
-
In a fascinating report by IQVIA Institute for Human Data Science, the authors highlight that the reason oncology timelines are likely increasing is…
In a fascinating report by IQVIA Institute for Human Data Science, the authors highlight that the reason oncology timelines are likely increasing is…
Beliebt bei Jorge Cancela
-
We are seeking a Working Student (m/f/d) for PVP Advisors, a "spin-off" of Peppermint VenturePartners. PVP Advisors offers strategic advice and…
We are seeking a Working Student (m/f/d) for PVP Advisors, a "spin-off" of Peppermint VenturePartners. PVP Advisors offers strategic advice and…
Beliebt bei Jorge Cancela
-
Effectiveness of digital health interventions for telemedicine/telehealth for managing blood pressure in adults: a systematic review and…
Effectiveness of digital health interventions for telemedicine/telehealth for managing blood pressure in adults: a systematic review and…
Geteilt von Jorge Cancela
Weitere ähnliche Profile
Weitere Mitglieder, die Jorge Cancela heißen
-
Jorge Cancela
Diretor empresa JCCOR - JORGE CANCELA UNIPESSOAL LDA Diretor empresa JC COATINGS SOLUTIONS - JORGE CANCELA UNIPESSOAL LDA
-
Jorge Cancela
Management Associate at Sonae Sierra
-
Jorge Cancela
Associate Professor na Faculdade de Arquitetura - Universidade de Lisboa
-
Jorge Cancela
Analista SAP at Brisa
Es gibt auf LinkedIn 43 weitere Personen, die Jorge Cancela heißen.
Weitere Mitglieder anzeigen, die Jorge Cancela heißen